![Duane Dorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Duane Dorn
Finanzdirektor/CFO bei CDx Diagnostics, Inc.
Aktive Positionen von Duane Dorn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Geschäftsführer | 01.04.2020 | - |
Finanzdirektor/CFO | - | - |
Karriereverlauf von Duane Dorn
Ausbildung von Duane Dorn
St. Bonaventure University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
- Börse
- Insiders
- Duane Dorn
- Erfahrung